DOT1L and acute lymphoblastic leukemia: To induce acquired resistance to DOT1L inhibition, the KMT2A::AFF1+ ALL cell line SEM [22] was exposed to increasing concentrations of the first-in-class DOT1L inhibitor pinometostat for 14 weeks (Fig. 1A).